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1. Introduction
Obstructive sleep apnea syndrome (OSAS) is a highly 
prevalent disorder characterized by repetitive episodes 
of airflow cessation termed as apnea, or reduction 
termed as hypopnea despite persistent thoracic and 
abdominal respiratory effort during sleep (1). Clinical and 
epidemiological data suggest an independent association 
between OSAS and systemic arterial hypertension, 
pulmonary hypertension, coronary artery disease, cardiac 
arrhythmias, heart failure, and sudden cardiac death (2). 
Meanwhile many studies have also shown an association 
between OSAS and impaired arterial distensibility (3). It is 
considered an early manifestation of adverse structural and 
functional changes in the vessel wall (4). Previous studies 
have mainly focused on the properties of aortic arterial 
distensibility, showing that it is an important predictor of 
cardiovascular morbidity and mortality in both the general 
population and in patients with OSAS (5). However, 
currently, only limited data exist for pulmonary artery 
distensibility in OSAS patients and its impact on right 
ventricular function. Hypoxia, such as occurs in OSAS, is 
thought to be responsible for endothelial dysfunction in the 
pulmonary vascular bed with consequent vasoconstriction 
and vascular remodeling (6). Impaired distensibility of 
the pulmonary arterial bed with subsequently increased 
load on the right ventricle may lead to right ventricular 
dysfunction and altered blood flow patterns throughout 
the lungs (7). Transthoracic echocardiography, which 
is noninvasive, can be used repeatedly with low medical 
cost and is one of the best methods to assess proximal 
pulmonary artery stiffness and the overall condition of the 
heart.
The purpose of this prospective study was to evaluate 
whether OSAS in different severities had any impact 
Background/aim: We investigated whether obstructive sleep apnea syndrome (OSAS) has any impact on pulmonary artery distensibility 
(PAD) and right ventricular (RV) function. 
Materials and methods: Subjects were categorized according to apnea–hypopnea index (AHI) as follows: controls (n = 17 and AHI < 
5), mild-to-moderate OSAS (n = 22 and AHI = 5–30), and severe OSAS (n = 29 and AHI > 30). All subjects underwent transthoracic 
echocardiography after polysomnography to assess PAD and RV function. PAD was recorded as M-Mode trace of the right pulmonary 
artery and was defined as (PAmax –PAmin/PAmin) × 100. S’ was measured by means of TDI of the lateral annulus of the RV using apical 
four-chamber view.
Results: Patients with severe OSAS demonstrated impaired RV longitudinal systolic function (S’) compared to the other groups (P < 
0.05). Impaired pulmonary vasculature elastic properties as reflected by decreased PAD were more prevalent in severe OSAS (26.2 ± 
5.7%) compared to the controls (29.9 ± 4.6%; P < 0.05) and mild-to-moderate OSAS (29.0 ± 4.1%; P < 0.05). An inverse relation between 
PAD (P < 0.05), RV myocardial performance index (MPI) (P < 0.05), and AHI was demonstrated. S’ also correlated with PAD (P < 
0.05). 
Conclusion: PAD is a significant tool to evaluate pulmonary vasculature stiffening and is well correlated with disease severity in OSAS. 
Further, impaired PAD may lead to RV systolic dysfunction.
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on pulmonary vasculature stiffening represented by 
pulmonary artery distensibility measured by transthoracic 
echocardiography. Further, we tried to elucidate the 
association between pulmonary artery stiffness symbolized 
by pulmonary artery distensibility measurement and right 
ventricular function. 
2. Materials and methods
2.1. Study design and patient population
The present study enrolled 68 of 92 consecutive subjects 
who underwent their initial polysomnography with a 
complete transthoracic echocardiogram within 1 week of 
their sleep study between January 2010 and January 2011. 
Twelve subjects were excluded because of inadequate 
image quality; 9 patients met the eligibility criteria but 
decided not to participate; 3 participants could not 
complete the full-night polysomnography and so their 
data were not evaluated. Data on the demographic 
characteristics, medical history, medications, laboratory 
values, and anthropometric measures were obtained before 
polysomnography. Height and weight were recorded at 
the time of polysomnography and were used to calculate 
the body mass index (weight in kilograms divided by 
height in square meters). Clinical information included a 
history of hypertension, defined as documented diagnosis, 
treatment such, or whether the recorded blood pressure 
was ≥140/90 mmHg. Dyslipidemia was defined according 
to the European Dyslipidemia Guidelines of 2016, as the 
use of lipid lowering therapy or documented diagnosis of 
dyslipidemia. Diabetes was defined as a fasting glucose 
level ≥ 126 mg/dL or receiving therapy with insulin and/
or oral hypoglycemic agents. Coronary artery disease was 
defined as previous myocardial infarction, percutaneous 
coronary intervention, or coronary bypass graft surgery. 
Smoking status was classified as current, past, or never. 
Exclusion criteria were defined as follows: participants 
under 18 years, patients with left ventricular dysfunction 
(left ventricular EF < 50%), cardiac surgery (valve and 
coronary artery bypass grafting) or coronary artery disease, 
presence of a permanent pacemaker, moderate-to-severe 
valvular heart disease, cardiomyopathies, and pulmonary 
hypertension due to identifiable causes. Further, subjects 
with previous use of continuous positive airway pressure 
treatment, cancer and/or other important comorbidities 
with an expected survival under 2 years, morbid obesity 
(BMI ≥ 40 kg/m2), heart rhythm except sinus rhythm, and 
suboptimal echocardiographic images for measurements 
were excluded from the study. To assess whether OSAS 
affects pulmonary artery stiffness independently of 
pulmonary pressure, we excluded patients with an 
estimated pulmonary systolic pressure > 40 mmHg and 
who had severe chronic obstructive pulmonary disorder. 
Informed consent was obtained from the subjects. This 
cross-sectional study was approved by the Institutional 
Review Board of our institution. 
2.2. Polysomnography 
Standard overnight polysomnography was performed 
in all subjects by Embla Flaga N7000. Polysomnography 
included the following variables: electro-oculogram, 
six electroencephalogram channels, bipolar surface 
electromyograms of submentalis and bilateral anterior 
tibialis muscles, and position sensors to record body 
position and movements. Respiratory monitoring 
consisted of oro-nasal thermistor and nasal cannula, 
tracheal microphone, thoracic and abdominal 
respiratory effort (Piezo belts), finger pulse-oxymetry, 
and electrocardiogram, as well as simultaneous video 
recording. Sleep staging was performed according to the 
guideline (8). Apnea was defined as a complete cessation 
of airflow for at least 10 s. Hypopnea was defined as an 
at least 50% decrease in baseline in airflow accompanied 
by 3% desaturation and/or associated with arousal, or 30% 
drop of nasal pressure baseline signal accompanied by 4% 
desaturation lasting at least 10 s. Apnea–hypopnea index 
was defined as the number of apneas and hypopneas per 
hour of sleep. The groups were defined as control subjects 
(AHI, <5), mild-to-moderate OSAS (AHI = 5–30), and 
severe OSAS (AHI ≥ 30).
2.3. Echocardiographic measurements
All echocardiographic measurements were performed 
by a single experienced cardiologist who was unaware 
of the clinical and laboratory variables of the patients. 
The intra-observer variability was 7.2%, representing 
acceptable accuracy and reproducibility of data. The 
echocardiographic examination was performed with 
subjects in the left lateral decubitus position using a 
commercially available ultrasound system with a 2.5–3.5 
MHz transducer (ie33, Phillips Medical System, Bothell, 
WA, USA). Left ventricular ejection fraction (EF) was 
estimated using Simpson’s biplane method. The right 
pulmonary artery was evaluated from the suprasternal 
view by echocardiography. An M-mode cursor was 
oriented along the right pulmonary artery diameter. 
M-mode traces were recorded at a speed of 100 mm/s. 
Maximum (PAmx) and minimum (PAmin, at the R 
peak) right pulmonary artery diameters were measured. 
The leading edge to leading edge method was used for 
measurements. Right pulmonary artery distensibility 
was defined as follows: (PAmx – PAmin/PAmin) × 100 
as previously described (Figure 1) (9). The pulmonary 
artery systolic pressure (sPAP) was calculated by adding 
the pressure gradient through the tricuspid valve obtained 
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by tricuspid regurgitation to right atrial pressure. Right 
ventricular fractional area change (FAC) was measured 
(10). Although it excludes the right ventricular outflow 
tract it is a simple surrogate marker of right ventricular 
ejection fraction. Tissue Doppler imaging was used to 
obtain the right ventricular myocardial velocities (S’) 
in the apical four-chamber view with a sample volume 
placed at the lateral segment of the tricuspid annulus. 
The parameters necessary for calculation of MPI were 
obtained by tissue Doppler in the apical four-chamber 
view (11). Tricuspid annular plane systolic excursion 
(TAPSE) represents the distance of systolic excursion of 
the right ventricular annular plane towards the apex and is 
measured as the maximum apical excursion of the lateral 
tricuspid annular plane as previously described (7).
2.4. Statistical analysis
To assess baseline difference across the study groups, we 
used one-way analysis of variance of continuous variables 
and the chi-squared test for categorical variables. Pearson’s 
correlation coefficient was used for determining the 
correlation between different laboratory and clinical 
parameters. Correlation analysis was performed using 
univariate clinical and laboratory variables. The statistical 
boundary was accepted as 0.05. Statistical analysis was 
performed using a statistical software package (SPSS, Inc., 
Chicago, IL, USA). 
3. Results
We studied a total of 68 subjects (17 control subjects, 22 
mild-to-moderate OSAS, 29 severe OSAS). Table 1 presents 
the demographic characteristics of the patients included in 
the study. These characteristics did not show any significant 
differences among the groups except for beta-blocker 
usage and AHI. Table 2 compares the echocardiographic 
parameters. There was no difference regarding left ventricular 
EF between the groups. In regard to right ventricular systolic 
function, right ventricular FAC and TAPSE did not differ 
between the groups. However, longitudinal right ventricular 
systolic function was impaired in severe OSAS as reflected 
by S’. Furthermore, right ventricular MPI did not differ as 
a marker of global right ventricular systolic and diastolic 
function. Pulmonary vasculature was assessed by sPAP and 
it was shown that there was a significant trend to increase 
with disease severity compared to the controls. Pulmonary 
artery distensibility was shown to be significantly decreased 
in patients with severe OSAS (Figure 2). Only AHI and 
MPI had a significant correlation with pulmonary artery 
distensibility (Table 2; Figures 3 and 4). Furthermore, 
correlation analysis was performed, and AHI, S’, and MPI 
showed a significant correlation with pulmonary artery 
distensibility (P < 0.05) (Table 3). There was also a significant 
correlation between S’ and pulmonary artery distensibility 
(p<0.05) (Table 4).
Figure 1. Transthoracic echocardiographic view showing measurement of pulmonary artery distensibility. RPA, 
right pulmonary artery; min, minimal diameter; max, maximal diameter.
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Table 2. Echocardiographic parameters of the study population.
Variable Controlsn = 17
Mild-to-moderate OSAS n 
= 22
Severe OSAS
n = 29 P-value
LV EF, % 63.4 ± 2.5 63.6 ± 2.8 62.2 ± 4.4 0.294
RV FAC, % 52.0 ± 4.0 50.1 ± 4.2 49.5 ± 3.0 0.082
TAPSE, mm 22.6 ± 0.7 22.4 ± 1.0 22.3 ± 0.7 0.455
RV MPI 0.41 ± 0.03 0.44 ± 0.06 0.45 ± 0.06 0.126
S’, cm/s 12.3 ± 1.2 11.5 ± 1.2 11.0 ± 1.01 <0.05
PAmax, mm 27.4 ± 3.2 25.8 ± 2.6 26.9 ± 3.0 0.231
PAmin, mm 19.2 ± 3.0 18.3 ± 2.3 19.8 ± 2.4 0.143
PAD, % 29.9 ± 4.6 29.0 ± 4.1 26.2 ± 5.71,2 <0.05
sPAP, mmHg 25.5 ± 4.0 29.7 ± 4.31 30.5 ± 4.71 <0.05
Abbreviations: LV EF, left ventricular ejection fraction; RV FAC, right ventricular fractional area change; TAPSE, tricuspid annular 
plane systolic excursion; PAD, pulmonary artery distensibility; sPAP, systolic pulmonary artery pressure
1: P<0.05 vs. control group
2: P<0.05 vs. mild-to-moderate OSAS
Table 1.  Clinical characteristics and laboratory findings of study population.
Variable Controlsn = 17
Mild-to-moderate 
OSAS n = 22
Severe OSAS
n = 29 P-value
AHI 2.6 ± 1.1 16.6 ± 8.61 56.2 ± 19.21,2 <0.05
Male (%) 64.7 (11) 63.6 (14) 55.2 (16) 0.756
Age (years) 42.9 ± 13.1 41.4 ± 12.6 43.1 ± 11.1 0.885
Hypertension (%) 52.9 (9) 72.7 (16) 58.6 (17) 0.406
Diabetes mellitus (%) 5.9 (1) 13.6 (3) 27.6 (8) 0.147
Hyperlipidemia (%) 47.1 (8) 50.0 (11) 41.4 (12) 0.821
Smoking (%) 41.2 (7) 45.5 (10) 43.8 (14) 0.897
RAAS-Inhibitors (%) 47.1 (8) 45.5 (10) 51.7 (15) 0.897
Beta-blocking agents (%) 5.9 (1) 50.0 (11)1 24.1 (7)1 0.008
Calcium channel blocking agents (%) 17.6 (3) 9.1 (2) 20.7 (6) 0.528
BMI (kg/m2) 26.3 ± 1.4 27.2 ± 1.4 27.5 ± 2.2 0.347
Systolic BP (mmHg) 130.8 ± 10.6 132.5 ± 9.8 135.6 ± 9.2 0.243
Diastolic BP (mmHg) 80.8 ± 6.7 81.8 ± 8.8 84.6 ± 12.0 0.398
Resting HR (beats/minute) 74.3 ± 4.3 76.0 ± 7.2 76.3 ± 6.0 0.542
 
Abbreviations: AHI, apnea–hypopnea index; RAAS, renin–angiotensin–aldosterone system; BMI, body mass index; HR, heart rate
1: P < 0.05 vs. control group;      2: P < 0.05 vs. mild-to-moderate OSAS
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4. Discussion
In the present study we demonstrated that the pulmonary 
artery becomes less distensible in patients with OSAS. 
Further, pulmonary artery distensibility deteriorated with 
increasing severity of OSAS. The second main finding was 
impaired longitudinal systolic function (S’) of the right 
ventricular in severe OSAS patients.
The pulmonary artery is a low pressure, high 
distensibility system that acts to transform the high 
pulsatile right ventricular output into near steady flow at 
the capillary level (12). Pulmonary artery distensibility 
is a new index that can be used to evaluate the elastic 
properties of pulmonary arterial vasculature (13). 
Currently it is the best predictor of mortality from 
right ventricular failure (14). Arterial distensibility 
is mainly determined by structural and functional 
components of elastic properties. Since elastic fibers are 
the main load-bearing components of the arterial wall, 
disruption of the elastic properties could be responsible 
for arterial stiffness (15). It was reported that hypoxia, 
such as occurs in OSAS, may lead to such alterations by 
decreasing glycosaminoglycan and collagen (16). Another 
explanation is that intermittent nocturnal hypoxia may 
cause pulmonary arterial endothelial dysfunction, which 
in turn leads to vasoconstriction and vascular remodeling 
(6). In a previous study, Akdag et al. assessed aortofemoral 
distensibility in OSAS patients with a different parameter 
than ours by means of echocardiography. They used 
aortic velocity propagation and reported a significantly 
decreased value of this parameter for this patient group 
(3). Again the principle of nocturnal hypoxemia with 
consequent endothelial dysfunction was considered 
the main cause of vascular stiffness. A further study 
conducted by Kasikcioglu et al. demonstrated impaired 
aortic distensibility in patients with OSAS. They observed 
not only decreased aortic distensibility but also diastolic 
deterioration of the LV (17). In this context the aorta 
was not only considered a conduit delivering blood. Its 
elastic properties also affect left ventricular function with 
a possible remodeling of the left ventricle (18). Similar 
findings obtained for the aorta in OSAS patients were also 
reported for the pulmonary vascular bed. In patients with 
OSAS, Altıparmak et al. revealed significantly impaired 
pulmonary artery distensibility that was also positively 
correlated with AHI (19). 
Direct measurement of main pulmonary artery 
distensibility requires pressure measurements, which 
Figure 2. Relationship between pulmonary artery distensibility 
and obstructive sleep apnea severity.
Figure 3. Correlation between pulmonary artery distensibility 
and apnea–hypopnea-index.
Figure 4. Correlation between pulmonary artery distensibility 
and right ventricular myocardial performance index.
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can currently only be achieved by invasive right heart 
catheterization. Using alternative noninvasive metrics of 
stiffness would be desirable for the clinically indicated 
frequent follow-ups or screening tests or the assessment 
of treatment responses. In this context we chose 
echocardiography as a preferable method for evaluating 
the right pulmonary artery distensibility. Beside its 
noninvasiveness, it has high accuracy and speediness 
in assessing the overall condition of the heart. Although 
right pulmonary artery distensibility and main pulmonary 
artery distensibility may theoretically not be comparable, 
we decided to take the right pulmonary artery for 
measurement because of two reasons. First, the window 
takes advantage of the superior resolution of M-mode 
echocardiography in comparison to two-dimensional 
echocardiography. Second, because of similar arterial wall 
architecture, the elastic properties of the right and main 
pulmonary artery would not be expected to differ (20).
The second important finding of our study was an 
impaired right ventricular systolic function, which was 
evaluated by means of longitudinal right ventricular basal 
movement S’. This parameter has been validated against 
radionuclide angiography and has been shown to be an 
accurate reproducible parameter of right ventricular 
systolic function (21). Further, there was a correlation 
between right ventricular MPI and pulmonary artery 
distensibility. The pulmonary artery plays an important 
role in facilitating the transition from right ventricular 
pulsatile flow to the nearly steady flow at the capillary 
level with minimal energy expenditure. The preservation 
of this right ventricular-PA coupling is fundamental to 
the maintenance of right heart hemodynamics and of 
pressure function relationships throughout the pulmonary 
vascular tree (22). The pulmonary artery elasticity is 
an important factor governing this relationship, with 
increased stiffness leading to higher right ventricular 
pulsatile work load, decreased contractile performance, 
and enhanced energy transmission to smaller pulmonary 
vessels, resulting in further vascular damage (23–25). A 
recent study by Altıparmak et al. demonstrated also that 
pulmonary artery distensibility is associated with right 
ventricular systolic and diastolic parameters (19). They 
used right ventricular MPI, which is a global parameter 
of cardiac function combining both systole and diastole. 
This index was considerably higher in OSAS patients with 
impaired pulmonary artery distensibility compared to 
controls showing right ventricular distension, overload, 
and dysfunction. A further study by Mahfouz et al. 
evaluated the impact of pulmonary artery distensibility 
on right ventricular function and tricuspid regurgitation 
(TR) after successful percutaneous balloon mitral 
valvuloplasty (PBMV). They reported that pulmonary 
artery distensibility was an independent predictor of TR 
regression and sustained right ventricular functional 
improvement after successful PBMV (9).
With the recognition of the prognostic importance 
of pulmonary artery distensibility, its impact on right 
ventricular function and its contributory role in the 
development and progression of distal vessel small-
vessel proliferative vasculopathy, pulmonary artery 
distensibility is an attractive target for the treatment of 





Abbreviations: AHI, apnea–hypopnea index; PAD, pulmonary artery distensibility; 
sPAP, systolic pulmonary artery pressure




RV MPI –0.305 <0.05
sPAP –0.223 0.081
Abbreviations: AHI, apnea–hypopnea index; RV MPI, right ventricular myocardial 
performance index; sPAP, systolic pulmonary artery pressure
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the underlying disease. However, there is currently scarce 
literature showing that improvement of pulmonary artery 
distensibility might be linked to better clinical outcomes.
 4.1. Conclusion
We demonstrated impaired values for pulmonary artery 
distensibility in patients with OSAS. These values are 
well correlated with the severity of the disease. Further, 
impaired pulmonary artery distensibility may lead to 
right ventricular systolic dysfunction. In this context, 
assessment of proximal pulmonary artery distensibility by 
means of echocardiography could be an early and simple 
determinant of right ventricular dysfunction and a routine 
part of clinical evaluation.
4.2. Limitations
The first limitation is the rather small number of OSAS 
patients in each subgroup, which limits the power of 
comparison. Further studies with larger numbers are 
needed to assess the effects of OSAS on pulmonary artery 
distensibility and right ventricular function. Another 
major limitation is the lack of biochemical determination 
of cardiac loading conditions by brain natriuretic peptides, 
which have good correlation with diastolic and systolic 
abnormalities. Further, optimal assessment of pulmonary 
circulation is difficult with echocardiography due to short 
penetration depth and difficulties in obtaining appropriate 
acoustic position. Lastly, the possible effect of beta-blockers 
on the pulmonary artery system cannot be excluded.
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